Trophic Effect of Norepinephrine on Arterial Intima-Media and Adventitia Is Augmented by Injury and Mediated by Different α1-Adrenoceptor Subtypes
- 26 October 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 89 (9) , 815-822
- https://doi.org/10.1161/hh2101.098379
Abstract
In vivo studies have suggested that norepinephrine (NE) directly contributes to normal vascular wall growth and worsening of hypertrophy, atherosclerosis, and restenosis. However, it is unknown whether these effects are secondary to hemodynamic changes caused by systemic NE or α-adrenoceptor (AR) antagonists. Herein, we determined if NE directly stimulates growth of medial smooth muscle cells (SMCs) and adventitial fibroblasts (AFBs) that we have shown express α1-ARs in similar abundance. The rat aorta was isolated before injury, 4 days after, or 12 days after balloon injury, and maintained under circumferential tension in organ culture for 48 hours with 1 μmol/L NE. Intima-media and adventitia were separated and DNA content, protein synthesis, and protein content measured. In uninjured aorta, NE increased DNA and protein content similarly in adventitia, and increased only protein content in intima-media, suggesting AFB proliferation and SMC hypertrophy. In vessels isolated 4 or 12 days after injury, NE increased all 3 endpoints in both layers by up to 20-fold greater than in uninjured vessels. These effects were dose-dependent and were unaffected by α2- or β-AR blockade (except increased DNA content in adventitia that was also inhibited by α2-AR blockade). Intima-media growth was blocked by KMD3213 (α1A-AR antagonist) and adventitial growth by AH11110A (α1B-AR antagonist), whereas BMY7378 (α1D-AR antagonist) had no effect. NE decreased SMC marker proteins (eg, α-smooth muscle actin and desmin) and augmented the changes induced by injury. These data suggest that prolonged stimulation of α1A- and α1B-ARs induces growth of SMCs and AFBs, respectively, that is significantly augmented by injury.Keywords
This publication has 17 references indexed in Scilit:
- Failure of AH11110A to functionally discriminate between α1-adrenoceptor subtypes A, B and D or between α1- and α2-adrenoceptorsEuropean Journal of Pharmacology, 2001
- α1-Adrenoceptor Subtypes Differentially Couple to Growth Promotion and Inhibition in Chinese Hamster Ovary CellsBiochemical and Biophysical Research Communications, 2000
- Pharmacological analysis of the novel, selective α1‐adrenoceptor antagonist, KMD‐3213, and its suitability as a tritiated radioligandBritish Journal of Pharmacology, 1999
- Synthesis and Biological Profile of the Enantiomers of [4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin-1-yl]furan- 2-ylmethanone (Cyclazosin), a Potent Competitive α1B-Adrenoceptor AntagonistJournal of Medicinal Chemistry, 1996
- Long-term reduction of intimal hyperplasia by the selective alpha-1 adrenergic antagonist doxazosinBritish Journal of Surgery, 1992
- Presence of β- but not α-adrenoceptors in the rat jugular vein: autoradiographical evidenceEuropean Journal of Pharmacology, 1992
- Effect of α1-adrenoceptor blockade on the development of hypertension in the spontaneously hypertensive ratEuropean Journal of Pharmacology, 1992
- Role for prazosin in reducing the development of rabbit intimal hyperplasia after endothelial denudationBritish Journal of Surgery, 1989
- Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion sizeAtherosclerosis, 1988
- Adrenergic Regulation of Vascular Smooth MusclePublished by American Geophysical Union (AGU) ,1980